A Genome-Wide Screen for Promoter Methylation in Lung Cancer Identifies Novel Methylation Markers for Multiple Malignancies
David S. Shames(Gene Therapy Laboratory), John D. Minna(Center for Neuro-Oncology)
Cited by 274
Related Papers
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
|New England Journal of Medicine|2018|3.5k
Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab
|Nature Medicine|2018|1.2k
High-throughput oncogene mutation profiling in human cancer
|Nature Genetics|2007|996
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
|Cancer Cell|2021|930
ctDNA guiding adjuvant immunotherapy in urothelial carcinoma
|Nature|2021|603